Miriam Freimer, MD, clinical professor of neurology at The Ohio State University Wexner Medical Center, reflects on how findings from the RAISE-XT trial potentially translate to real-world practice ...

Esketamine monotherapy demonstrated beneficial antidepressant effects at multiple doses for patients with treatment-resistant depression, according to results of a phase 4 randomized trial published ...

Glucagon-like peptide-1 (GLP-1) receptor agonists significantly enhance overall survival in patients with ovarian cancer, offering a promising adjunct to traditional treatments.

The next major release of C++ reached an important milestone earlier this month, when the ISO C++ committee froze the feature set that will go into C++26. Notable additions include compile-time ...

A new clip from James Gunn's Superman reveals how evil the DCU's Lex Luthor truly is (and not even Krypto is safe).

NYC's Democratic mayoral primary features Trump as central antagonist with Cuomo and Mamdani battling amid immigration tensions, federal arrests and debates over the party's future.

Chronic pain affects millions of people in the US. Targeting an oft-overlooked brain receptor could one day offer relief.

Key takeaways: Maridebart cafraglutide is a dual GLP-1/GIP being investigated for the treatment of obesity and diabetes. Once-monthly dosing led to significant weight loss in adults with obesity ...

Orforglipron is a small-molecule, nonpeptide glucagon-like peptide-1 (GLP-1) receptor agonist in clinical development for type 2 diabetes and weight management. Additional data on the efficacy and ...

In alignment with the objective of rapid antidepressive treatment, each of these major techniques demonstrates distinct advantages: ECT and MST work through immediate neuromodulation, intravenous ...

After months of courting Republicans, the Democratic governor now warns Trump is undermining democracy with the military deployment in Los Angeles.